Oxford BioTherapeutics develops medicines for cancer and companion diagnostics for selected antibody programs.
MicrofluidX is a company that develops cell bioprocessing technology.
Affinia Therapeutics is a biotech company.
Nouscom is a biotech company working to develop a series of new, potent immunotherapeutics capable of selectively killing tumor cells.
Milton, GB HQ
San Jose, US
Basel, CH HQ
Latest funding round
Latest funding round$ 10m (about 6 years ago)
Latest funding round$ 1.7m (over 1 year ago)
Latest funding round$ 60m (over 1 year ago)
Latest funding round$ 49m (almost 4 years ago)
Total funding raised
Total funding raised$ 21.6m
Total funding raised$ 1.7m
Total funding raised$ 60m
Total funding raised$ 62.6m